NOTE 4 – EARNINGS (LOSS) PER SHARE INFORMATION

​

​

For the three months ended September 30, 2022, stock options to purchase 70,500 shares of common stock, 37,487 shares of unvested restricted stock units, and 860,212 shares of unvested performance stock units were excluded from the computation of diluted earnings per share as their effect would have been anti-dilutive. For the nine months ended September 30, 2022, stock options to purchase 70,500 shares of common stock, 11,312 shares of unvested restricted stock units, and 798,768 shares of unvested performance stock units were excluded from the computation of diluted earnings per share as their effect would have been anti-dilutive. For the three months ended September 30, 2021, stock options to purchase 70,500 shares of common stock and 14,709 shares of unvested restricted stock were excluded from the computation of diluted earnings per share as their effect would have been anti-dilutive. For the nine months ended September 30, 2021, 465,500 shares of common stock, 3,247,623 shares of unvested restricted stock, and unexercised common warrants of 29,519,500 were excluded from the computation of diluted earnings per share as their effect would have been anti-dilutive.